WP
ELV icon

Woodline Partners’s Elevance Health ELV Stock Holding History

Woodline Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,653
Closed -$6.92M – 1070
2026
Q1 		$6.92M Buy
23,653
+20,130
+571% +$6.62M 0.03% 596
2025
Q4 		$1.23M Buy
+3,523
New +$1.19M ﹤0.01% 824
2025
Q2 		– Sell
-131,036
Closed -$57M – 962
2025
Q1 		$57M Buy
131,036
+128,612
+5,306% +$51.6M 0.37% 69
2024
Q4 		$894K Buy
+2,424
New +$1.01M 0.01% 778
2024
Q2 		– Sell
-57,586
Closed -$29.9M – 594
2024
Q1 		$29.9M Buy
+57,586
New +$28.6M 0.27% 114
2022
Q3 		– Sell
-29,410
Closed -$14.2M – 775
2022
Q2 		$14.2M Buy
+29,410
New +$14.5M 0.22% 144
2020
Q2 		– Sell
-37,048
Closed -$8.41M – 161
2020
Q1 		$8.41M Buy
+37,048
New +$10.1M 0.6% 57

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Woodline Partners's ELV Position: Q2 2026 in Review

Woodline Partners sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 23,653 shares — an estimated $6.92M sold.

Woodline Partners first reported a position in ELV in Q1 2020 and held it in 7 quarters. The position peaked at $57M in Q1 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Woodline Partners reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Woodline Partners sold 23,653 Elevance Health shares in Q2 2026, an estimated $6.92M.
  • Woodline Partners first reported a position in Elevance Health in Q1 2020 and held it in 7 quarters.
  • Woodline Partners's Elevance Health position peaked at $57M in Q1 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.